WHO Prequalified Vaccines

 

Last updated:  04/06/2019
233 presentation(s) for 146 vaccine(s)
PrequalifiedTypeCommercial NamePharmaceutical FormPresentationNo. of DosesManufacturerResponsible NRA
26/09/2006Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type bQuinvaxemLiquid: ready to useVial1Janssen Vaccines Corp.Ministry of Food and Drug Safety
11/03/1999Diphtheria-Tetanus Adsorbed DT VaccineLiquid: ready to useVial10PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
06/04/2001Diphtheria-Tetanus-Pertussis (whole cell)DTP VaccineLiquid: ready to useVial10PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
13/05/2004Hepatitis BHepatitis B Vaccine Recombinant Liquid: ready to useUniject1PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
09/04/1997Polio Vaccine - Oral (OPV) TrivalentOral polioLiquid: ready to useVial10PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
09/04/1997Polio Vaccine - Oral (OPV) TrivalentOral polioLiquid: ready to useVial20PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
11/03/1999Tetanus ToxoidTT vaccineLiquid: ready to useVial10PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
11/03/1999Tetanus ToxoidTT vaccineLiquid: ready to useVial20PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
29/10/2003Tetanus ToxoidTT vaccineLiquid: ready to useUniject1PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
09/04/1997MeaslesMeasles vaccine Lyophilised active component to be reconstituted with excipient diluent before useVial + Ampoule10PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
17/10/2001Yellow FeverYellow FeverLyophilised active component to be reconstituted with excipient diluent before useTwo vial set (active + excipient)5Bio-Manguinhos/FiocruzAgencia Nacional da Vigilancia Sanitaria
10/12/2007Yellow FeverYellow FeverLyophilised active component to be reconstituted with excipient diluent before useTwo vial set (active + excipient)10Bio-Manguinhos/FiocruzAgencia Nacional da Vigilancia Sanitaria
17/10/2001Yellow FeverYellow FeverLyophilised active component to be reconstituted with excipient diluent before useTwo vial set (active + excipient)50Bio-Manguinhos/FiocruzAgencia Nacional da Vigilancia Sanitaria
11/12/2001Hepatitis BHeberbiovac HBLiquid: ready to useVial1Centro de Ingenieria Genetica y BiotecnologiaCentro para el Control Estatal de la Calidad de los Medicamentos
11/12/2001Hepatitis BHeberbiovac HBLiquid: ready to useVial10Centro de Ingenieria Genetica y BiotecnologiaCentro para el Control Estatal de la Calidad de los Medicamentos
10/04/2018RabiesRabipurLyophilised active component to be reconstituted with excipient diluent before useVial1Chiron Behring Vaccines Private Ltd.Central Drugs Standard Control Organization
18/08/1997Haemophilus influenzae type bVaxem HIBLiquid: ready to useVial1Novartis Vaccines and Diagnostics S.r.lAgenzia Italiana del Farmaco
01/01/1987Hepatitis BEngerixLiquid: ready to useVial1GlaxoSmithKline Biologicals SAFederal Agency for Medicines and Health Products
01/01/1987Hepatitis BEngerixLiquid: ready to useVial10GlaxoSmithKline Biologicals SAFederal Agency for Medicines and Health Products
01/01/1987Hepatitis BEngerixLiquid: ready to useVial20GlaxoSmithKline Biologicals SAFederal Agency for Medicines and Health Products
09/03/2001Measles, Mumps and RubellaPriorixLyophilised active component to be reconstituted with excipient diluent before useVial1GlaxoSmithKline Biologicals SAFederal Agency for Medicines and Health Products
12/03/2009Rotavirus RotarixLiquid: ready to usePlastic Tube1GlaxoSmithKline Biologicals SAFederal Agency for Medicines and Health Products
02/02/2006Polio Vaccine - Oral (OPV) TrivalentPolioviral vaccineLiquid: ready to useVial20Haffkine Bio Pharmaceutical Corporation LtdCentral Drugs Standard Control Organization
20/03/2001Yellow FeverStabilized Yellow Fever VaccineLyophilised active component to be reconstituted with excipient diluent before useVial5Institut Pasteur de DakarMinistère de la Santé publique
20/03/2001Yellow FeverStabilized Yellow Fever VaccineLyophilised active component to be reconstituted with excipient diluent before useVial20Institut Pasteur de DakarMinistère de la Santé publique
20/03/2001Yellow FeverStabilized Yellow Fever VaccineLyophilised active component to be reconstituted with excipient diluent before useVial10Institut Pasteur de DakarMinistère de la Santé publique
01/01/1987BCGBCG Freeze Dried Glutamate vaccineLyophilised active component to be reconstituted with excipient diluent before useAmpoule20Japan BCG LaboratoryPharmaceutical and Medical Devices Agency
22/11/1996Hepatitis BEuvax BLiquid: ready to useVial1LG Chem LtdMinistry of Food and Drug Safety
22/11/1996Hepatitis BEuvax BLiquid: ready to useVial10LG Chem LtdMinistry of Food and Drug Safety
01/02/1991BCGBCG VaccineLyophilised active component to be reconstituted with excipient diluent before useAmpoule10BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.)Bulgarian Drug Agency
01/02/1991BCGBCG VaccineLyophilised active component to be reconstituted with excipient diluent before useAmpoule20BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.)Bulgarian Drug Agency
09/05/2006Tetanus ToxoidTetatoxLiquid: ready to useVial10BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.)Bulgarian Drug Agency
09/05/2006Tetanus ToxoidTetatoxLiquid: ready to useVial20BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.)Bulgarian Drug Agency
09/05/2006Diphtheria-TetanusDiftetLiquid: ready to useVial10BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.)Bulgarian Drug Agency
09/05/2006Diphtheria-TetanusDiftetLiquid: ready to useVial20BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.)Bulgarian Drug Agency
09/05/2006Diphtheria-Tetanus (reduced antigen content)TetadifLiquid: ready to useVial10BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.)Bulgarian Drug Agency
09/05/2006Diphtheria-Tetanus (reduced antigen content)TetadifLiquid: ready to useVial20BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.)Bulgarian Drug Agency
02/10/2013Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type bEasyfive-TTLiquid: ready to useVial10Panacea Biotec Ltd.Central Drugs Standard Control Organization
22/07/1997Diphtheria-Tetanus (reduced antigen content)IMOVAX dT adultLiquid: ready to useVial10Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
09/12/2005Polio Vaccine - Inactivated (IPV)IMOVAX POLIOLiquid: ready to useVial10Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
16/06/2002Polio Vaccine - Oral (OPV) TrivalentOPVEROLiquid: ready to useVial10Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
16/06/2002Polio Vaccine - Oral (OPV) TrivalentOPVEROLiquid: ready to useVial10Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
16/06/2002Polio Vaccine - Oral (OPV) TrivalentOPVEROLiquid: ready to useVial20Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
22/07/1997Tetanus ToxoidTETAVAXLiquid: ready to useVial10Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
22/07/1997Tetanus ToxoidTETAVAXLiquid: ready to useVial20Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
01/04/1998Haemophilus influenzae type bAct-HIBLyophilised active component to be reconstituted with excipient diluent before useVial1Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
22/06/2005RabiesVERORABLyophilised active component to be reconstituted with excipient diluent before useVial1Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
01/01/1987Yellow FeverSTAMARILLyophilised active component to be reconstituted with excipient diluent before useVial10Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
08/05/2008Polio Vaccine - Oral (OPV) Monovalent Type 1ORAL MONOVALENT TYPE 1 POLIOMYELITIS VACCINELiquid: ready to useVial20Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
25/10/2001cholera: inactivated oralDukoralLiquid: ready to useVial + Buffer Sachet1Valneva Sweden ABMedical Products Agency
12345



Count of vaccines is determined based on unique combination for:
[Vaccine Type] [Product Commercial Name] [Product Pharmaceutical Form] [Manufacturer] [Manufacturer Country]